Back

Tolerability and short-term outcomes of angiotensin receptor-neprilysin inhibitor (ARNI) use in a Singaporean cohort

30 April 2017 (08:30 - 18:00)
Organised by:
Congress Presentation Part of: Poster Session 2 - Chronic heart failure Diuretics HFA Premium Access Heart Failure 2017 - 4th World Congress on Acute Heart Failure

About the speaker

Photo
Doctor Natalie Koh

National Heart Centre Singapore, Singapore (Singapore)

91 More presentations in this session

Presentation thumbnail
Assistant Professor D. Hashemi (Berlin, DE)
Presentation thumbnail
Doctor B. Narziev (Tashkent, UZ)
Presentation thumbnail
Presentation thumbnail
Doctor D. Nascimento Matos (Carnaxide, PT)
Abstract
Presentation thumbnail
Doctor F. Ricupati (Palermo, IT)
Abstract Slides

Access the full session

Session thumbnail
Poster Session 2 - Chronic heart failure

The Event

Event poster

Heart Failure 2017 - 4th World Congress on Acute Heart Failure

30 April 2017 08:30 CET
You may be interested in
thumbnail
Congress Presentation
Age-stratified and sex-stratified effect of angiotensin receptor-neprilysin inhibitor in heart failure with reduced ejection fraction-data from PARADE-HF: nationwide medication adherence study
12 May 2024
thumbnail
Congress Session
Implementation of the 2024 ESC Guidelines for the Management of Elevated Blood Pressure and Hypertension: insights from Hong Kong
31 August 2025
thumbnail
Congress Presentation
Effect of renin angiotensin system inhibitors on long-term major cardiovascular outcomes in patients with high atherosclerotic cardiovascular risk
23 May 2023
thumbnail
Congress Presentation
Sacubitril/Valsartan efficacy on functional, laboratory, echocardiographic parameters: a real-world study
29 June 2021

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources